Evidence map›Paper›PMID 21989943›Full record

ReviewMolecular imaging and biology2012

Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.

Arvind Chopra, Liang Shan, W C Eckelman, Kam Leung, Martin Latterner, Stephen H Bryant, Anne Menkens

Abstract readReview
In one paragraph

Review in Molecular imaging and biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 54 citations in OpenAlex.

  1. Head-to-head comparison ofEJNMMI research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Prospective ofContrast media & molecular imaging · 2018
    Review
  12. Article
  13. Advancing biomedical imaging.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Review
  14. Review
  15. Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arvind ChopraNational Center of Biotechnology Information, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, USA. chopraa@mail.nih.gov
Liang Shan
W C Eckelman
Kam Leung
Martin Latterner
Stephen H Bryant
Anne Menkens
National Center for Biotechnology Information · USNational Cancer Institute · USUnited States National Library of Medicine · US

Funding

Structural Biology Information ResourcesZIALM000046 · NLM · NATIONAL LIBRARY OF MEDICINE · PI BRYANT, STEPHEN H · 2009 to 2017
$45.4M
Chemical Biology Information ResourcesZIALM100604 · NLM · NATIONAL LIBRARY OF MEDICINE · PI BRYANT, STEPHEN H · 2009 to 2017
$39.6M
Intramural NIH HHS Z99 CL999999Intramural NIH HHS Z99 HL999999Intramural NIH HHS Z99 LM999999Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

The purpose of writing this review is to showcase the Molecular Imaging and Contrast Agent Database (MICAD; www.micad.nlm.nih.gov ) to students, researchers, and clinical investigators interested in the different aspects of molecular imaging. This database provides freely accessible, current, online scientific information regarding molecular imaging (MI) probes and contrast agents (CA) used for positron emission tomography, single-photon emission computed tomography, magnetic resonance imaging, X-ray/computed tomography, optical imaging and ultrasound imaging. Detailed information on >1,000 agents in MICAD is provided in a chapter format and can be accessed through PubMed. Lists containing >4,250 unique MI probes and CAs published in peer-reviewed journals and agents approved by the United States Food and Drug Administration as well as a comma separated values file summarizing all chapters in the database can be downloaded from the MICAD homepage. Users can search for agents in MICAD on the basis of imaging modality, source of signal/contrast, agent or target category, pre-clinical or clinical studies, and text words. Chapters in MICAD describe the chemical characteristics (structures linked to PubChem), the in vitro and in vivo activities, and other relevant information regarding an imaging agent. All references in the chapters have links to PubMed. A Supplemental Information Section in each chapter is available to share unpublished information regarding an agent. A Guest Author Program is available to facilitate rapid expansion of the database. Members of the imaging community registered with MICAD periodically receive an e-mail announcement (eAnnouncement) that lists new chapters uploaded to the database. Users of MICAD are encouraged to provide feedback, comments, or suggestions for further improvement of the database by writing to the editors at micad@nlm.nih.gov.

Indexed as

Contrast MediaDatabase Management SystemsDatabases, FactualDiagnostic ImagingMolecular ImagingAnimalsHumansInternetMolecular ProbesUser-Computer InterfaceContrast MediaMolecular Probes

Identifiers

PMID21989943
PMCPMC3259264
OpenAlexW2168463112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.